Genomic Surveillance Enables the Identification of Co-infections With Multiple SARS-CoV-2 Lineages in Equatorial Guinea.
Central-Africa
SARS-CoV-2
co-infection
genomic surveillance
variant of concern
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2021
2021
Historique:
received:
19
11
2021
accepted:
30
11
2021
entrez:
21
1
2022
pubmed:
22
1
2022
medline:
28
1
2022
Statut:
epublish
Résumé
COVID-19 disease caused by SARS-CoV-2 represents an ongoing global public health emergency. Rapid identification of emergence, evolution, and spread of SARS-CoV-2 variants of concern (VOC) would enable timely and tailored responses by public health decision-making bodies. Yet, global disparities in current SARS-CoV-2 genomic surveillance activities reveal serious geographical gaps. Here, we discuss the experiences and lessons learned from the SARS-CoV-2 monitoring and surveillance program at the Public Health Laboratory on Bioko Island, Equatorial Guinea that was implemented as part of the national COVID-19 response and monitoring activities. We report how three distinct SARS-CoV-2 variants have dominated the epidemiological situation in Equatorial Guinea since March 2020. In addition, a case of co-infection of two SARS-CoV-2 VOC, Beta and Delta, in a clinically asymptomatic and fully COVID-19 vaccinated man living in Equatorial Guinea is presented. To our knowledge, this is the first report of a person co-infected with Beta and Delta VOC globally. Rapid identification of co-infections is relevant since these might provide an opportunity for genetic recombination resulting in emergence of novel SARS-CoV-2 lineages with enhanced transmission or immune evasion potential.
Identifiants
pubmed: 35059385
doi: 10.3389/fpubh.2021.818401
pmc: PMC8763705
doi:
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
818401Informations de copyright
Copyright © 2022 Hosch, Mpina, Nyakurungu, Borico, Obama, Ovona, Wagner, Rubin, Vickos, Milang, Ayekaba, Phiri, Daubenberger and Schindler.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Curr Biol. 2021 Jul 26;31(14):R918-R929
pubmed: 34314723
Anal Chem. 2021 Dec 14;93(49):16350-16359
pubmed: 34852455
Cell. 2021 Sep 30;184(20):5179-5188.e8
pubmed: 34499854
J Clin Microbiol. 2021 Jul 19;59(8):e0092621
pubmed: 34011523
Sci Rep. 2021 Oct 14;11(1):20494
pubmed: 34650153
PLoS Biol. 2021 May 7;19(5):e3001236
pubmed: 33961632
Front Cell Infect Microbiol. 2021 May 20;11:672562
pubmed: 34123874
Cell Host Microbe. 2021 Mar 10;29(3):463-476.e6
pubmed: 33592168
Comput Struct Biotechnol J. 2022;20:4015-4024
pubmed: 35915661
Cell Host Microbe. 2021 Mar 10;29(3):477-488.e4
pubmed: 33535027
bioRxiv. 2020 Sep 04;:
pubmed: 32908977
J Clin Microbiol. 2021 Jul 19;59(8):e0085921
pubmed: 34037430
Science. 2021 Oct 22;374(6566):423-431
pubmed: 34672751
Cell. 2020 Nov 12;183(4):1024-1042.e21
pubmed: 32991844
Science. 2016 Jan 1;351(6268):81-4
pubmed: 26678874
PLoS One. 2014 Sep 02;9(9):e106534
pubmed: 25180686
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Nat Commun. 2021 Oct 1;12(1):5769
pubmed: 34599175